LOGIN
 
Share Page:
Back

Volume 37 , Issue 2
March/April 2022

Pages 320327


Effect of Ti-Base Abutment Gingival Height on Maintenance of Crestal Bone in Thick Biotype Patients: A Randomized Clinical Trial with 1-Year Follow-up

Tomas Linkevicius, DDS, PhD, Prof/Jonas Alkimavicius, DDS/Rokas Linkevicius, MD/Evelina Gineviciute, DDS/Laura Linkeviciene, DDS, PhD, Prof


DOI: 10.11607/jomi.9406

Purpose: To determine the effect of 0.7- and 2.4-mm transmucosal abutment height titanium bases on the crestal bone stability and peri-implant soft tissue condition of bone-level implants with platform switching in patients with vertically thick soft tissues. Materials and Methods: Sixty bone-level platform-switched implants were placed in the molar and premolar regions of both arches in 60 patients. All epicrestally inserted nonsubmerged implants had a 4.1-mm diameter and, after osteointegration, were randomly allocated into two groups: (1) the short group, with a titanium base of 0.7-mm transmucosal abutment height, and (2) the high group with a 2.4-mm height. Monolithic zirconia restorations were fabricated for all implants. Parallel intraoral radiographs were obtained after the delivery of restorations (T1) and after 1 year (T2). Crestal bone levels and peri-implant soft tissue conditions were calculated for each implant. The significance level was set at α = .05. Results: After 1 year, 55 patients were evaluated, with a mean bone loss of 0.6 ± 0.51 mm (median: 0.71, range: 0 to 2.09 mm) in the short group (23 patients) and 0.45 ± 0.59 mm (median: 0.65, range: 0 to 2.12 mm) in the high group (22 patients), showing no significant difference between groups (P = .168). A significant increase in marginal bone height was noted between the T1 and T2 time points in the short and high (P = .029 and .001, respectively) groups. The peri-implant soft tissue health parameters did not show statistically significant differences. Conclusion: Crestal bone stability after 1 year of follow-up around epicrestally placed platform-switched implants is not influenced by transmucosal abutment height, if the vertical soft tissue thickness is ≥ 3 mm.


Full Text PDF File | Order Article

 

 
Get Adobe Reader
Adobe Acrobat Reader is required to view PDF files. This is a free program available from the Adobe web site.
Follow the download directions on the Adobe web site to get your copy of Adobe Acrobat Reader.

 

© 2022 Quintessence Publishing Co, Inc JOMI Home
Current Issue
Ahead of Print
Archive
Author Guidelines
About
Accepted Manuscripts
Submission Form
Submit
Reprints
Permission
Advertising
Quintessence Home
Terms of Use
Privacy Policy
About Us
Contact Us
Help